Tirzepatide is a high-purity lyophilized peptide researched for its unique ability to act as a dual agonist for both the Glucose-dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-1 (GLP-1) receptors. Originally designed to investigate synergistic metabolic pathways, it has become a primary subject of study in fat metabolism and weight management research. This TRZ-2 product provides a consistent and stable reagent for academic and industrial research into molecular signaling, peptide behavior, and tissue remodeling. It is intended strictly for laboratory and research development purposes only.
Reviews
There are no reviews yet.